Douglas T. Fearon - Concepedia

Author

Douglas T. Fearon

Also Known As

D FEARON, D T FEARON, D T Fearon, D. T. Fearon, D.T. Fearon, DOUGLAS T. FEARON, Douglas Fearon, Douglas T Fearon, Douglas T. Fearon, Douglas Thomas Fearon

310

Publications

41.6K

Citations

H-Index

187

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital University of Cambridge Wellcome Trust Cold Spring Harbor Laboratory

About

Douglas T. Fearon is an author at Harvard University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	61	93	19.5K
2	Natural Sciences	21	21	3K
3	Health Sciences	2	2	169
4	Engineering	1	1	51
5	Public Health	1	1	41

Douglas T. Fearon

135

Publications

28.6K

Citations

H-Index

Page 1

	Year	Citations
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer Daniel Öhlund, Abram Handly-Santana, Giulia Biffi, The Journal of Experimental Medicine PathologyDistinct SubpopulationCancer BiologyTumor BiologyCaf Heterogeneity	2017	2.3K
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer Christine Feig, James O. Jones, Matthew Kraman, Proceedings of the National Academy of Sciences	2013	1.9K
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice Jean Albrengues, Mario A. Shields, David Ng, Science	2018	1.4K
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity Paul W. Dempsey, Michael Allison, Srinivas Akkaraju, Science Bridging InnateAdaptive Immune SystemInnate Immune SystemImmunologyHumoral Response	1996	1.2K
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I Keisuke Yamamoto, Anthony Venida, Julian Yano, Nature Cell AutophagyImmune EvasionPancreatic CancerImmunologyAutophagy	2020	1.1K
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α Matthew Kraman, Paul Bambrough, James N. Arnold, Science Fap-expressing CellsImmunologyImmune RegulationImmunoeditingImmunologic Mechanism	2010	1.1K
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis Harlan F. Weisman, Michelle K. Leppo, Henry C. Marsh, Science ImmunologyImmunologic MechanismPost-ischemic Myocardial InflammationImmunotherapyInflammation	1990	977
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Joyce D. Fingeroth, Joachim Weis, Thomas F. Tedder, Proceedings of the National Academy of Sciences Epstein-barr Virus ReceptorImmunologyPathologyImmunotherapyEpstein-barr Virus	1984	938
Distinct fibroblast subsets drive inflammation and damage in arthritis Adam P. Croft, Joana Campos, Kathrin Jansen, Nature InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRheumatic Diseases	2019	881
CD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes Robert H. Carter, Douglas T. Fearon Science Autoimmune DiseaseAntigen Receptor StimulationHematologyImmunologyImmunodominance	1992	673

Page 1